University of British Columbia, Canada
Researchers from Canada, the People's Republic of China and the United States publish new studies and findings in the area of cancer
Published in Genetics and Environmental Business Week, August 17th, 2006
Study 1: In a recent study, researchers from Canada reported on the induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide (ASO) targeting Bcl-2 and Bcl-xL genes.
K. Yamanaka and colleagues, University British Columbia, wrote that the study was done "to determine whether a specifically designed bispecific (Bcl-2/Bcl-xL) antisense oligonucleotide (ASO) induces apoptosis and enhances chemosensitivity in human prostate cancer LNCaP cells, as Bcl-2 and Bcl-xL are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Baylor Health Care System, U.S.
Melanoma vaccine is focus of Baylor Institute for Immunology Research grant - Abbott
UroVysion DNA Test superior to standard cytology in diagnosing bladder cancer, study shows - Agilent Technologies
Agilent Technologies' high-resolution genomic coverage microarrays now available - Arca Discovery
Arca Discovery discusses genetic basis for enhanced response to bucindolol - Baylor College of Medicine, U.S.
Recent findings from the United States, Sweden and Japan illuminate research in diabetes - Cardiovascular Institute, Tokyo
Recent studies from Japan and the United States add new data to cardiology research - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
